{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-014962","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2025-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.284738+00:00","generated_at":"2026-05-17T05:39:54.864838+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Akari Therapeutics extends April 2023 notes to Aug 2026, closes $500k tranche, reveals PH1 ADC data","bullets":["April 2023 notes maturity extended to Aug 31, 2026; conversion/exercise price amended to $0.81/ADS ($0.000405 per ordinary share).","Paid ~$81,700 accrued interest through Sep 30, 2025; default claims released.","Closed second tranche of August 2025 Notes: issued $625k principal for $500k; total $3.5M principal issued.","April 2023 warrants exp. extended to Aug 2030, 342,420 ADSs issuable; Series A warrants exp. extended to Apr 2030 for 4,891,272 ADSs.","Preclinical data: PH1 ADC suppresses AR-V7 in mCRPC model; plans to present at scientific conference."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-014962","json":"https://secwatch.observer/filing/0001493152-25-014962.json","markdown":"https://secwatch.observer/filing/0001493152-25-014962.md","text":"https://secwatch.observer/filing/0001493152-25-014962.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225014962/0001493152-25-014962-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000149315225014962/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:39:54.864838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}